E
Strata Skin Sciences, Inc.
SSKN
$2.89
$0.2911.15%
E
Sell
5/22/2024Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 5/22/2024 due to a decline in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 5/22/2024 due to a decline in the volatility index and total return index.
D
Sell
5/7/2024Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 5/7/2024 due to a noticeable increase in the solvency index, volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 5/7/2024 due to a noticeable increase in the solvency index, volatility index and total return index.
E
Sell
3/28/2024Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 3/28/2024 due to a major decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0302 to -$0.1083, EBIT declined 88.13% from -$615 to -$1.16M, and debt to equity increased from 0.95 to 1.21.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 3/28/2024 due to a major decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0302 to -$0.1083, EBIT declined 88.13% from -$615 to -$1.16M, and debt to equity increased from 0.95 to 1.21.
D
Sell
3/18/2024Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 3/18/2024 due to an increase in the total return index and volatility index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 3/18/2024 due to an increase in the total return index and volatility index.
E
Sell
2/27/2024Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 2/27/2024 due to a decline in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 2/27/2024 due to a decline in the volatility index.
D
Sell
2/9/2024Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index and valuation index.
E
Sell
1/12/2024Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 1/12/2024 due to a decline in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 1/12/2024 due to a decline in the volatility index.
D
Sell
12/27/2023Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 12/27/2023 due to an increase in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 12/27/2023 due to an increase in the volatility index.
E
Sell
12/6/2023Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 12/6/2023 due to a decline in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 12/6/2023 due to a decline in the volatility index and total return index.
D
Sell
11/20/2023Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 11/20/2023 due to a major increase in the growth index, solvency index and volatility index. EBIT increased 68.65% from -$1.96M to -$615, earnings per share increased from -$0.0902 to -$0.0302, and total revenue increased 7.3% from $8.25M to $8.85M.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 11/20/2023 due to a major increase in the growth index, solvency index and volatility index. EBIT increased 68.65% from -$1.96M to -$615, earnings per share increased from -$0.0902 to -$0.0302, and total revenue increased 7.3% from $8.25M to $8.85M.
E
Sell
10/5/2023Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 10/5/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.41 to 0.91.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 10/5/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.41 to 0.91.
D
Sell
3/14/2023Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 03/14/2023.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 02/08/2023.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 02/08/2023.
D
Sell
1/24/2023Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 1/24/2023 due to a decline in the volatility index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 1/24/2023 due to a decline in the volatility index and valuation index.
D
Sell
1/6/2023Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 1/6/2023 due to an increase in the volatility index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 1/6/2023 due to an increase in the volatility index and valuation index.
D
Sell
12/22/2022Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 12/22/2022 due to a decline in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 12/22/2022 due to a decline in the volatility index and total return index.
D
Sell
12/2/2022Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 12/2/2022 due to an increase in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 12/2/2022 due to an increase in the volatility index.
D
Sell
11/16/2022Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 11/16/2022 due to a noticeable decline in the solvency index, growth index and volatility index. Operating cash flow declined 1,139.29% from -$56 to -$694, the quick ratio declined from 0.91 to 0.78, and debt to equity increased from 0.34 to 0.35.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 11/16/2022 due to a noticeable decline in the solvency index, growth index and volatility index. Operating cash flow declined 1,139.29% from -$56 to -$694, the quick ratio declined from 0.91 to 0.78, and debt to equity increased from 0.34 to 0.35.
D
Sell
8/12/2022Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 8/12/2022 due to a noticeable increase in the growth index, valuation index and solvency index. Operating cash flow increased 84.14% from -$353 to -$56, total revenue increased 29.31% from $7.04M to $9.11M, and EBIT increased 26.44% from -$2.3M to -$1.69M.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 8/12/2022 due to a noticeable increase in the growth index, valuation index and solvency index. Operating cash flow increased 84.14% from -$353 to -$56, total revenue increased 29.31% from $7.04M to $9.11M, and EBIT increased 26.44% from -$2.3M to -$1.69M.
D
Sell
7/13/2022Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 7/13/2022 due to a noticeable decline in the total return index and volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 7/13/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from E+ on 5/16/2022 due to an increase in the solvency index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from E+ on 5/16/2022 due to an increase in the solvency index.
E
Sell
5/13/2022Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/1/2022Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 5/1/2022 due to a decline in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/20/2022Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index and volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell
11/16/2021Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 11/16/2021 due to an increase in the solvency index and total return index. The quick ratio increased from 0.7 to 1.33, and debt to equity declined from 0.32 to 0.29.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 11/16/2021 due to an increase in the solvency index and total return index. The quick ratio increased from 0.7 to 1.33, and debt to equity declined from 0.32 to 0.29.
D
Sell
11/8/2021Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D+ on 11/8/2021 due to a decline in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D+ on 11/8/2021 due to a decline in the volatility index.
D
Sell
11/3/2021Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 11/3/2021 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.0715 to $0.03, EBIT increased 61.41% from -$2.39M to -$923, and operating cash flow increased 52.94% from $153 to $234.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 11/3/2021 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.0715 to $0.03, EBIT increased 61.41% from -$2.39M to -$923, and operating cash flow increased 52.94% from $153 to $234.
D
Sell
8/3/2021Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 8/3/2021 due to an increase in the volatility index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 8/3/2021 due to an increase in the volatility index and valuation index.
D
Sell
7/19/2021Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 7/19/2021 due to a large decline in the growth index, solvency index and volatility index. EBIT declined 579.55% from -$352 to -$2.39M, earnings per share declined from -$0.0131 to -$0.0715, and operating cash flow declined 55.78% from $346 to $153.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 7/19/2021 due to a large decline in the growth index, solvency index and volatility index. EBIT declined 579.55% from -$352 to -$2.39M, earnings per share declined from -$0.0131 to -$0.0715, and operating cash flow declined 55.78% from $346 to $153.
D
Sell
3/26/2021Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 3/26/2021 due to a noticeable decline in the growth index and valuation index. Operating cash flow declined 36.98% from $549 to $346.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 3/26/2021 due to a noticeable decline in the growth index and valuation index. Operating cash flow declined 36.98% from $549 to $346.
D
Sell
1/22/2021Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 1/22/2021 due to a substantial increase in the growth index, total return index and volatility index. Total revenue increased 39.28% from $4.03M to $5.61M, EBIT increased 28.11% from -$1.62M to -$1.16M, and earnings per share increased from -$0.0498 to -$0.04.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 1/22/2021 due to a substantial increase in the growth index, total return index and volatility index. Total revenue increased 39.28% from $4.03M to $5.61M, EBIT increased 28.11% from -$1.62M to -$1.16M, and earnings per share increased from -$0.0498 to -$0.04.
D
Sell
9/10/2020Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 9/10/2020 due to an increase in the total return index, volatility index and growth index. Operating cash flow increased 0.84% from $598 to $603.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 9/10/2020 due to an increase in the total return index, volatility index and growth index. Operating cash flow increased 0.84% from $598 to $603.
D
Sell
5/20/2020Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 5/20/2020 due to a significant decline in the growth index, total return index and efficiency index. EBIT declined 1,563.16% from -$57 to -$948, net income declined 100.97% from -$515 to -$1.04M, and earnings per share declined from -$0.0153 to -$0.0307.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 5/20/2020 due to a significant decline in the growth index, total return index and efficiency index. EBIT declined 1,563.16% from -$57 to -$948, net income declined 100.97% from -$515 to -$1.04M, and earnings per share declined from -$0.0153 to -$0.0307.
D
Sell
3/3/2020Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 3/3/2020 due to a decline in the volatility index, total return index and growth index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 3/3/2020 due to a decline in the volatility index, total return index and growth index.
D
Sell
12/4/2019Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 12/4/2019 due to an increase in the valuation index, growth index and total return index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 12/4/2019 due to an increase in the valuation index, growth index and total return index.
D
Sell
11/19/2019Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 11/19/2019 due to a noticeable decline in the growth index, valuation index and solvency index. The quick ratio declined from 1.74 to 1.63, debt to equity increased from 0.26 to 0.27, and total revenue declined 3.17% from $7.73M to $7.48M.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 11/19/2019 due to a noticeable decline in the growth index, valuation index and solvency index. The quick ratio declined from 1.74 to 1.63, debt to equity increased from 0.26 to 0.27, and total revenue declined 3.17% from $7.73M to $7.48M.
D
Sell
11/15/2019Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 11/15/2019 due to a major increase in the growth index and efficiency index. EBIT increased 20.79% from -$1.24M to -$983, earnings per share increased from -$0.0396 to -$0.0321, and net income increased 18.83% from -$1.33M to -$1.08M.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 11/15/2019 due to a major increase in the growth index and efficiency index. EBIT increased 20.79% from -$1.24M to -$983, earnings per share increased from -$0.0396 to -$0.0321, and net income increased 18.83% from -$1.33M to -$1.08M.
D
Sell
9/24/2019Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 9/24/2019 due to a decline in the total return index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 9/24/2019 due to a decline in the total return index and valuation index.
D
Sell
9/3/2019Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 9/3/2019 due to an increase in the volatility index and valuation index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 9/3/2019 due to an increase in the volatility index and valuation index.
D
Sell
8/19/2019Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 8/19/2019 due to a decline in the volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 8/19/2019 due to a decline in the volatility index.
D
Sell
8/2/2019Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 8/2/2019 due to an increase in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 8/2/2019 due to an increase in the volatility index and total return index.
D
Sell
5/23/2019Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 5/23/2019 due to a noticeable decline in the total return index and volatility index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D from D+ on 5/23/2019 due to a noticeable decline in the total return index and volatility index.
D
Sell
11/19/2018Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 11/19/2018 due to a major increase in the total return index, growth index and solvency index. Operating cash flow increased 1,555.47% from -$128 to $1.86M, EBIT increased 94.5% from -$946 to -$52, and earnings per share increased from -$0.058 to -$0.0086.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D+ from D on 11/19/2018 due to a major increase in the total return index, growth index and solvency index. Operating cash flow increased 1,555.47% from -$128 to $1.86M, EBIT increased 94.5% from -$946 to -$52, and earnings per share increased from -$0.058 to -$0.0086.
D
Sell
8/7/2018Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 8/7/2018 due to a noticeable increase in the volatility index, total return index and efficiency index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 8/7/2018 due to a noticeable increase in the volatility index, total return index and efficiency index.
D
Sell
5/8/2018Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 5/8/2018 due to an increase in the growth index, total return index and efficiency index. Operating cash flow increased 244.99% from $549 to $1.89M, earnings per share increased from -$5.5077 to -$0.4416, and net income increased 87.42% from -$13.67M to -$1.72M.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 5/8/2018 due to an increase in the growth index, total return index and efficiency index. Operating cash flow increased 244.99% from $549 to $1.89M, earnings per share increased from -$5.5077 to -$0.4416, and net income increased 87.42% from -$13.67M to -$1.72M.
E
Sell
2/20/2018Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 2/20/2018 due to a decline in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 2/20/2018 due to a decline in the volatility index and total return index.
D
Sell
11/17/2017Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 11/17/2017 due to a significant decline in the growth index and efficiency index. Net income declined 1,034.52% from -$1.21M to -$13.67M, earnings per share declined from -$0.52 to -$5.5077, and EBIT declined 277.67% from $309 to -$549.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 11/17/2017 due to a significant decline in the growth index and efficiency index. Net income declined 1,034.52% from -$1.21M to -$13.67M, earnings per share declined from -$0.52 to -$5.5077, and EBIT declined 277.67% from $309 to -$549.
D
Sell
12/23/2016Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 12/23/2016 due to a significant increase in the growth index, solvency index and efficiency index. Operating cash flow increased 375.28% from -$178 to $490, EBIT increased 72.22% from -$1.46M to -$405, and earnings per share increased from -$0.2337 to -$0.1413.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D from D- on 12/23/2016 due to a significant increase in the growth index, solvency index and efficiency index. Operating cash flow increased 375.28% from -$178 to $490, EBIT increased 72.22% from -$1.46M to -$405, and earnings per share increased from -$0.2337 to -$0.1413.
D
Sell
5/20/2016Upgraded
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 5/20/2016 due to an increase in the growth index, total return index and efficiency index.
Strata Skin Sciences, Inc. (SSKN) was upgraded to D- from E+ on 5/20/2016 due to an increase in the growth index, total return index and efficiency index.
E
Sell
3/14/2016Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 3/14/2016 due to a decline in the volatility index and total return index.
Strata Skin Sciences, Inc. (SSKN) was downgraded to E+ from D- on 3/14/2016 due to a decline in the volatility index and total return index.
D
Sell
3/11/2016Downgrade
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.65 to 1.28, and the quick ratio declined from 0.56 to 0.48.
Strata Skin Sciences, Inc. (SSKN) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.65 to 1.28, and the quick ratio declined from 0.56 to 0.48.
NASDAQ
03/12/2025 11:22AM Eastern
Quotes delayed
